Table 1 The underlying condition and prior antibiotics use in the 66 patients with invasive S. pyogenes infection
Underlying condition | N | % | Previous antibiotics | N | % |
|---|---|---|---|---|---|
Leukemia | 2 | 3.0 | Azithromycin, IV × 2–5 d | 7 | 10.6 |
Varicella | 2 | 3.0 | Cephalosporins, Oral × 3–5 d | 3 | 4.6 |
Skin burn | 2 | 3.0 | Azithromycin, Oral ×3 d | 1 | 1.5 |
Skin hemangioma | 2 | 3.0 | Erythromycin, Oral ×3 d | 1 | 1.5 |
Nephrotic syndrome | 1 | 1.5 | Piperacillin-tazobactam, IV × 1 d | 1 | 1.5 |
Still’s disease | 1 | 1.5 | Erythromycin, IV × 1 d; | 1 | 1.5 |
Clindamycin, IV × 1 d | |||||
Cerebral trauma | 1 | 1.5 | Azithromycin, IV × 5 d; | 1 | 1.5 |
Clindamycin, IV × 1 d | |||||
Craniocerebral trauma | 1 | 1.5 | Meropenem + vancomycin + | 1 | 1.5 |
Metronidazole, IV × 3 d | |||||
Cerebrospinal fluid rhinorrhea | 1 | 1.5 | Meropenem, IV × 3 d; | 1 | 1.5 |
Lynezoliane, IV × 1 d | |||||
None | 53 | 80.5 | Piperacillin-tazobactam, IV × 1 d; | 1 | 1.5 |
Clindamycin, IV × 4 d; | 1 | 1.5 | |||
Vancomycin + Mezlocillin, IV × 1d | |||||
None | 47 | 71.3 | |||
Total | 66 | 100 | Total | 66 | 100 |